Rhythm Pharmaceuticals buy Wells Fargo & Company
Start price
10.07.25
/
50%
€75.50
Target price
10.07.26
€109.86
Performance (%)
22.52%
Price
02.02.26
€84.50
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan currently has a performance of 22.52%. This prediction currently runs until 10.07.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | -2.874% | -2.874% |
| iShares Core DAX® | -0.436% | 1.181% |
| iShares Nasdaq 100 | 0.854% | 1.475% |
| iShares Nikkei 225® | 2.652% | 6.401% |
| iShares S&P 500 | 1.190% | 1.169% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target raised by analysts at Wells Fargo & Company from $91.00 to $129.00. They now have an "overweight" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€50.50
07.04.25
07.04.25
€82.88
07.04.26
07.04.26
83.17%
02.02.26
02.02.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€42.40
19.12.23
19.12.23
€48.34
19.12.24
19.12.24
30.90%
20.12.24
20.12.24
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€26.00
08.11.23
08.11.23
€37.40
08.11.24
08.11.24
140.38%
09.11.24
09.11.24